前言。 - Suppr | 超能文献

Suppr

超能文献

Preface.

作者信息

Walker Richard I, Riddle Mark S, Clifford Allison

机构信息

Center for Vaccine Innovation and Access, PATH, Washington, DC, USA.

School of Medicine, Uniformed Services University, Bethesda, MD, USA.

出版信息

Vaccine. 2019 Aug 7;37(34):4767. doi: 10.1016/j.vaccine.2019.06.085. Epub 2019 Jul 9.

DOI:10.1016/j.vaccine.2019.06.085

PMID:31300286

Abstract

摘要

相似文献

Preface.

Vaccine. 2019 Aug 7;37(34):4767. doi: 10.1016/j.vaccine.2019.06.085. Epub 2019 Jul 9.

Vaccines Against Shigella and Enterotoxigenic Escherichia coli: A summary of the 2018 VASE Conference.

Vaccine. 2019 Aug 7;37(34):4768-4774. doi: 10.1016/j.vaccine.2019.02.070.

Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development.

Vaccine. 2019 Aug 7;37(34):4787-4793. doi: 10.1016/j.vaccine.2019.03.040. Epub 2019 Jun 20.

Technical product attributes in development of an oral enteric vaccine for infants.

Vaccine. 2019 Aug 7;37(34):4800-4804. doi: 10.1016/j.vaccine.2019.02.060.

Capturing the true burden of Shigella and ETEC: The way forward.

Vaccine. 2019 Aug 7;37(34):4784-4786. doi: 10.1016/j.vaccine.2019.01.031. Epub 2019 Jan 31.

Using advocacy to increase investment in enteric vaccine development.

Vaccine. 2019 Aug 7;37(34):4811-4813. doi: 10.1016/j.vaccine.2018.12.033. Epub 2019 Feb 5.

Implications and measurement of herd protection (indirect effects) for enteric vaccine development.

Vaccine. 2019 Aug 7;37(34):4775-4777. doi: 10.1016/j.vaccine.2019.02.061.

How genomics can be used to understand host susceptibility to enteric infection, aiding in the development of vaccines and immunotherapeutic interventions.

Vaccine. 2019 Aug 7;37(34):4805-4810. doi: 10.1016/j.vaccine.2019.01.016. Epub 2019 Jan 29.

Clinical endpoints for efficacy studies.

Vaccine. 2019 Aug 7;37(34):4814-4822. doi: 10.1016/j.vaccine.2019.03.051. Epub 2019 Apr 10.

Combination vaccine strategies to prevent enteric infections.

Vaccine. 2017 Dec 14;35(49 Pt A):6790-6792. doi: 10.1016/j.vaccine.2017.06.076. Epub 2017 Jul 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Preface.

Vaccine. 2019 Aug 7;37(34):4767. doi: 10.1016/j.vaccine.2019.06.085. Epub 2019 Jul 9.

Vaccines Against Shigella and Enterotoxigenic Escherichia coli: A summary of the 2018 VASE Conference.

Vaccine. 2019 Aug 7;37(34):4768-4774. doi: 10.1016/j.vaccine.2019.02.070.

Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development.

Vaccine. 2019 Aug 7;37(34):4787-4793. doi: 10.1016/j.vaccine.2019.03.040. Epub 2019 Jun 20.

Technical product attributes in development of an oral enteric vaccine for infants.

Vaccine. 2019 Aug 7;37(34):4800-4804. doi: 10.1016/j.vaccine.2019.02.060.

Capturing the true burden of Shigella and ETEC: The way forward.

Vaccine. 2019 Aug 7;37(34):4784-4786. doi: 10.1016/j.vaccine.2019.01.031. Epub 2019 Jan 31.

Using advocacy to increase investment in enteric vaccine development.

Vaccine. 2019 Aug 7;37(34):4811-4813. doi: 10.1016/j.vaccine.2018.12.033. Epub 2019 Feb 5.

Implications and measurement of herd protection (indirect effects) for enteric vaccine development.

Vaccine. 2019 Aug 7;37(34):4775-4777. doi: 10.1016/j.vaccine.2019.02.061.

How genomics can be used to understand host susceptibility to enteric infection, aiding in the development of vaccines and immunotherapeutic interventions.

Vaccine. 2019 Aug 7;37(34):4805-4810. doi: 10.1016/j.vaccine.2019.01.016. Epub 2019 Jan 29.

Clinical endpoints for efficacy studies.

Vaccine. 2019 Aug 7;37(34):4814-4822. doi: 10.1016/j.vaccine.2019.03.051. Epub 2019 Apr 10.

Combination vaccine strategies to prevent enteric infections.

Vaccine. 2017 Dec 14;35(49 Pt A):6790-6792. doi: 10.1016/j.vaccine.2017.06.076. Epub 2017 Jul 10.